亏损收窄股价却缩水四成，2100亿沐曦股份怎么了？

Core Viewpoint - Muxi Co., Ltd., a prominent domestic GPU chip giant, is facing challenges despite its rapid revenue growth, as it continues to report significant losses and high R&D expenditures [4][10][21]. Group 1: Financial Performance - Muxi Co., Ltd. expects to achieve revenue between 400 million to 600 million yuan in Q1 2026, representing a year-on-year growth of 24.84% to 87.26% [8]. - The company anticipates a net profit loss attributable to shareholders of 90.76 million to 182 million yuan for the same period, although this loss is narrower than the 233 million yuan loss reported in the same quarter last year [9][10]. - The total net profit loss for the year 2025 was reported at 781 million yuan, indicating ongoing financial struggles [11]. Group 2: Market Position and Challenges - Muxi Co., Ltd. has a strong background with a core team from renowned companies like AMD, which has helped it gain significant attention in the capital market since its establishment in 2020 [15][18]. - The company has faced a decline in stock price, dropping 40% from its peak, with a current market capitalization of 213.5 billion yuan [20][21]. - Despite impressive revenue growth rates in previous years, the company is experiencing a slowdown, with 2025 revenue growth at 121.26% compared to extraordinary rates of 12334.6% and 1301.46% in 2023 and 2024, respectively [12][13]. Group 3: R&D and Product Dependency - Muxi Co., Ltd. has heavily invested in R&D, with expenditures of 648 million, 699 million, and 901 million yuan from 2022 to 2024, accounting for 282.11% of cumulative revenue during that period [23]. - The company relies significantly on its Xiyun C500 series chip, which accounted for 97.28% and 97.87% of its main business revenue in 2024 and Q1 2025, respectively [26][27]. - High customer concentration is a concern, with the top five customers contributing 100%, 91.58%, 71.09%, and 88.35% of revenue in the respective years, indicating vulnerability to changes in demand from these clients [28].